Takayasu Arteritis

Takayasu arteritis is a rare inflammatory disease of large blood vessels, especially the aorta and its major branches. Because inflammation can narrow, block, or weaken the affected arteries, the disease may reduce blood flow to important organs and tissues. It is sometimes called “pulseless disease” because pulses in the arms may become weak or difficult to detect. ^[1][2]

Early symptoms may be nonspecific and easy to overlook. Fatigue, low-grade fever, night sweats, weight loss, muscle pain, and general malaise may appear before more obvious vascular signs develop. As the disease progresses, symptoms related to reduced blood flow may become more prominent, such as arm pain with activity, dizziness, headache, fainting, shortness of breath, visual problems, chest pain, or differences in blood pressure between the two arms. ^[1][3]

The arteries most commonly involved are the aorta and its major branches, including vessels supplying the arms, brain, kidneys, and sometimes the heart. Because the pattern of involvement varies from person to person, symptoms can also differ considerably. In some people the disease is detected after difficult-to-control hypertension, whereas in others it becomes apparent because of limb fatigue, neurologic symptoms, or signs of reduced blood flow. ^[1][2][3]

Diagnosis often requires a combination of clinical suspicion, blood tests, and imaging studies. Inflammatory markers such as ESR and CRP may be elevated, but they do not by themselves prove the diagnosis. Imaging is central to evaluation. Ultrasound, CT angiography, MR angiography, or conventional angiography may show vessel wall thickening, narrowing, dilation, or aneurysm formation. Clinicians also pay close attention to pulse asymmetry, bruits, and blood pressure differences between limbs. ^[1][3]

Treatment aims to suppress inflammation and prevent vascular damage. Corticosteroids are commonly used, especially at the beginning of therapy. Because long-term steroid exposure carries risks and relapse can occur, other immunosuppressive or biologic medications may be added in selected patients. The exact drug choice depends on disease activity, organ involvement, treatment response, and side-effect profile. ^[1][3]

Some patients may need vascular procedures or surgery if critical narrowing, severe blood flow compromise, aneurysm formation, or major organ risk is present. However, whenever possible, interventions are planned after inflammation is better controlled, because active disease may increase procedural complications. This makes regular follow-up especially important. ^[1][3]

Potential complications include stroke, uncontrolled hypertension, aortic valve problems, aneurysms, heart failure, and reduced blood flow to organs or limbs. Because some of these complications can develop gradually, people with Takayasu arteritis usually need long-term monitoring even when symptoms appear stable. ^[1][2][3]

Daily life management includes taking medication as prescribed, attending regular follow-up visits, monitoring blood pressure carefully, and reporting new neurologic symptoms, chest pain, limb weakness, or worsening exertional symptoms promptly. The disease course may fluctuate, and periods of relative stability do not necessarily mean that monitoring can stop. ^[1][3]

Urgent evaluation is needed if there is sudden weakness, visual loss, severe chest pain, significant shortness of breath, fainting, or signs suggesting stroke or critical limb ischemia. In a rare large-vessel vasculitis such as Takayasu arteritis, early recognition of complications can substantially affect outcomes. ^[1][3]